https://www.selleckchem.com/pr....oducts/rocaglamide.h
3%). Two TIA occurred during the hospitalization period, one in each group (1/41, 2.4% vs 1/47, 2.1%). One patient of the Casper group had an asymptomatic in-stent thrombosis. One patient of the control group had aMI (1/47, 2.1%) after discharge. The Casper stents did not show superiority in the rate of incidence, number and size of new silent ischemic brain lesions detect by DW-MRI when compared to close cell stents during CAS under distal EPD. The Casper stents did not show superiority in the rate of incidence, number and size of
Like
Comment
Share
